|
Event Brief of Isis Pharmaceuticals' Clinical Development Goals Conference Call - Final
Fair Disclosure Wire; 2/10/2006; 787 words
; ... Disclosure Wire 02-10-2006 PARTICIPANTS . Stanley Crooke, ISIS Pharmaceuticals, Chairman & CEO . Claudine Prowse, ISIS Pharmaceuticals, Executive Director, Corporate Development OVERVIEW ISIS announced its clinical development goals for 2006. ISIS ...
Read more
|
|
Event Brief of Isis Pharmaceuticals Conference Call - Final
Fair Disclosure Wire; 4/28/2006; 787 words
; ... Disclosure Wire 04-28-2006 PARTICIPANTS . Stanley Crooke, ISIS Pharmaceuticals, Chairman & CEO . Navjot Rai, ISIS Pharmaceuticals, Assistant Director, Corporate Communications. . Mark Wedel, ISIS Pharmaceuticals, SVP, Development & Chief Medical ...
Read more
|
|
Event Brief of Q4 2006 Isis Pharmaceuticals Earnings Conference Call - Final
Fair Disclosure Wire; 3/8/2007; 787 words
; Fair Disclosure Wire 03-08-2007 PARTICIPANTS . Dr. Stan Crooke, Isis Pharmaceuticals, Inc., Chairman, CEO . Kate Corcoran, Isis Pharmaceuticals, Inc., VP, Corp. Dev. . Lynne Parshall, Isis Pharmaceuticals, Inc., EVP, CFO, Secretary . Jeffrey Jonas ...
Read more
|
|
Isis International-Manila seeks new executive director. (Isis Currents).
WE!; 6/1/2003; 787 words
; The General Members, Board of Trustees and Staff of Isis International-Manila invite candidates to apply for the position of Executive Director of Isis. isis International-Manila is a 30-year old international women ...
Read more
|
|
Event Brief of Q1 2007 Isis Pharmaceuticals Earnings Conference Call - Final
Fair Disclosure Wire; 5/10/2007; 787 words
; Fair Disclosure Wire 05-10-2007 PARTICIPANTS . Stan Crooke, Isis Pharmaceuticals, Inc., Chairman, CEO . Lynne Parshall, Isis Pharmaceuticals, Inc., EVP, CFO . Jeff Jonas, Isis Pharmaceuticals, Inc., EVP . Kate Corcoran, Isis Pharmaceuticals ...
Read more
|
|
Event Brief of Q1 2006 Isis Pharmaceuticals Earnings Conference Call - Final
Fair Disclosure Wire; 5/2/2006; 787 words
; ... Wire 05-02-2006 PARTICIPANTS . Dr. Stanley Crooke, ISIS Pharmaceuticals, Chairman, CEO . Lynne Parshalle, ISIS Pharmaceuticals, EVP, CFO . Navjot Rai, ISIS Pharmaceuticals, Assistant Director, CC . Mark Monane, Needham & Co, Analyst OVERVIEW ISIS reported that it has continued to realize the ...
Read more
|
|
Q4 2006 Isis Pharmaceuticals Earnings Conference Call - Final
Fair Disclosure Wire; 3/8/2007; 787 words
; ... Wire 03-08-2007 OPERATOR: Welcome to the Isis Pharmaceuticals conference call. Today ... Leading the call today is Dr. Stan Crooke, Isis Chairman and CEO. Dr. Crooke, please go ahead. DR. STAN CROOKE, CHAIRMAN, CEO, ISIS PHARMACEUTICALS, INC.: Thank you, Char ...
Read more
|
|
Isis' Talbut first to go in F&C merger.
Investment Adviser; 7/5/2004; 526 words
; by nigel davies Isis' chief investment officer Robert Talbut ... C. Mr Talbut, who manages the AGBP10.5m Isis Managed Distribution fund, will stay with ... has emerged between the two companies. Isis said there would be redundancies on both ...
Read more
|
|
Isis makes metal music for the thinking man.
Idaho Statesman (Boise, ID); 3/30/2007; 787 words
; ... Deeds Mar. 30--For a decade, art-metal band Isis has banged its head while stimulating the ... 18th-century philosopher Jeremy Bentham, Isis released In the Absence of Truth. The lyrics ... permitted. Beer-swilling Ozzfest material Isis is not. I'm not going to claim that we ...
Read more
|
|
Q1 2007 Isis Pharmaceuticals Earnings Conference Call - Final
Fair Disclosure Wire; 5/10/2007; 787 words
; ... 2007 OPERATOR: Good day, everyone, and welcome to Isis Pharmaceuticals first quarter earnings conference ... call is being recorded. Leading the call today from Isis is Dr. Stan Crooke, Isis Chairman and CEO. Dr. Crooke, please go ahead, sir ...
Read more
|